# Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease

> **NCT02111122** · PHASE2 · COMPLETED · sponsor: **Christian Baumann** · enrollment: 16 (actual)

## Conditions studied

- Sleep-wake Disturbances in Motor-phase Parkinson's Disease

## Interventions

- **DRUG:** Sodium Oxybate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02111122
- **Lead sponsor:** Christian Baumann
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111122, "Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02111122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*